Aberrant T‑Cell Marker Expression in EBV Negative Plasmablastic Lymphoma in a Transplant Patient: Expanding an Unusual Immunophenotypic Spectrum
2026 ASCP/CAP-ACP Annual Meeting · 18 November 2026 · 12:00–12:45 · 517ABC - Exhibit Hall
Aberrant T‑Cell Marker Expression in EBV Negative Plasmablastic Lymphoma in a Transplant Patient: Expanding an Unusual Immunophenotypic Spectrum was a session at 2026 ASCP/CAP-ACP Annual Meeting on 18 November 2026 in Montreal, with 1 speaker on record.
Speakers
- Shahad Iqneibi — Speaker Medical Resident- Pathology and Laboratory Medicine, Emory University Hospital